Dissemination of drug abuse against youth in the sukoharjo area
DOI:
https://doi.org/10.59247/jppmi.v2i11.175Keywords:
drugs, dependency, youthAbstract
NAPZA stands for Narcotics, Alcohol, Psychotropics and other Addictive Substances, including natural or synthetic substances which, when consumed, cause changes in physical and psychological functions, as well as lead to dependence. Counseling is carried out directly with initial introductions and followed by filling out pretests, presentation of material using power points about drug abuse against adolescents. Then continued the game session, filling out the questionnaire. The results of the analysis of the pretest and posttest values using SPSS with the Paired Sample T-test experienced a significant change with a significance value (2-tailed). The active participation of activity participants can be demonstrated with a 100% attendance rate. The results of the pre test and post test showed an increase by all participants. The success indicator of counseling is seen from the understanding of the entire material delivered by the extension worker.
References
M. Dehghan, A. Malakoutikhah, H. Kazemy, M. H. Fattahi Toqroljerdi, S. Mokhtarabadi, and M. A. Zakeri, “The relationship between beliefs in substance craving and quality of life among narcotics anonymous: a cross-sectional study in southeastern Iran,” BMC Psychol., vol. 11, no. 1, p. 126, Apr. 2023.
S. Mustafa et al., “One immune system plays many parts: The dynamic role of the immune system in chronic pain and opioid pharmacology,” Neuropharmacology, vol. 228, p. 109459, May 2023.
F. Estrada, O. Bäckman, and A. Nilsson, “Biased Enforcement Expansion? Sociodemographic Differences in Police Drug Testing for Suspected Narcotics Use 1993–2015,” Br. J. Criminol., vol. 62, no. 5, pp. 1213–1232, Sep. 2022.
M. A. Strand, H. N. Eukel, O. Frenzel, E. Skoy, J. Steig, and A. Werremeyer, “Opioid risk stratification in the community pharmacy: The utility of the Opioid Risk Tool,” Res. Soc. Adm. Pharm., vol. 18, no. 12, pp. 4065–4071, Dec. 2022.
S.-Y. Kim, N.-W. Cho, M.-S. Yoo, S.-Y. Han, and J.-W. Oh, “Narcotics information management system in South Korea: system development and innovation,” BMC Health Serv. Res., vol. 23, no. 1, p. 73, Jan. 2023.
M. Carnevale Miino, T. Macsek, T. Halešová, T. Chorazy, and P. Hlavínek, “Pharmaceutical and narcotics monitoring in Brno wastewater system and estimation of seasonal effect on the abuse of illicit drugs by a wastewater-based epidemiology approach,” Sci. Total Environ., vol. 891, p. 164386, Sep. 2023.
C. Schmitt-Koopmann, C.-A. Baud, V. Junod, and O. Simon, “Switzerland’s Narcotics Regulation Jungle: Off-Label Use, Counterfoil Prescriptions, and Opioid Agonist Therapy in the French-Speaking Cantons,” Int. J. Environ. Res. Public Health, vol. 18, no. 24, p. 13164, Dec. 2021.
F. Reifferscheid, “Anwendung von BtMG-gelisteten Opiaten und Opioiden durch Notfallsanitäter/-innen als Teil eines analgetischen Gesamt- konzeptes in der prähospitalen Notfallmedizin,” Der Notarzt, vol. 37, no. 06, pp. 351–353, Dec. 2021.
E. W. Guo et al., “Older, Male Orthopaedic Surgeons From Southern Geographies Prescribe Higher Doses of Post-Operative Narcotics Than do their Counterparts: A Medicare Population Study,” Arthrosc. Sport. Med. Rehabil., vol. 3, no. 6, pp. e1577–e1583, Dec. 2021.
K. F. Lim and X. Su, “Cross‐border market building for narcotics control: A Polanyian analysis of the China–Myanmar border region,” Trans. Inst. Br. Geogr., vol. 46, no. 4, pp. 834–849, Dec. 2021.
N. Richardson-Little, “Cold War Narcotics Trafficking, the Global War on Drugs, and East Germany’s Illicit Transnational Entanglements,” Cent. Eur. Hist., vol. 56, no. 2, pp. 214–235, Jun. 2023.
C. B. Rosen and M. S. Altieri, “Comment on: How much narcotics are really needed after bariatric surgery: results of a prospective study,” Surg. Obes. Relat. Dis., vol. 19, no. 6, pp. 546–547, Jun. 2023.
R. F. Walton et al., “Variation in care between pediatric and adult patients presenting with nephrolithiasis to tertiary care pediatric emergency departments in the United States (2009–2020),” J. Pediatr. Urol., vol. 18, no. 6, pp. 742.e1-742.e11, Dec. 2022.
F. Lotfi Kashani, S. Vaziri, and A. Vaziri, “Effects of Methamphetamine and Narcotics on Sexual High-Risk Behaviors,” Int. J. High Risk Behav. Addict., vol. 11, no. 3, p. 253, Sep. 2022.
R. Wilson, S. A. Said, S. Rydzinski, J. Gutnick, A. Aminian, and T. Augustin, “How much narcotics are really needed after bariatric surgery: results of a prospective study,” Surg. Obes. Relat. Dis., vol. 19, no. 6, pp. 541–546, Jun. 2023.
Y. Lu et al., “Effect of lidocaine perioperative infusion on chronic postsurgical pain in patients undergoing thoracoscopic radical pneumonectomy,” BMC Anesthesiol., vol. 22, no. 1, p. 255, Aug. 2022.
L. B. Gerlach, L. Zhang, J. Strominger, J. Teno, J. P. W. Bynum, and D. T. Maust, “State variation in antipsychotic and benzodiazepine prescribing among hospice beneficiaries in the United States,” J. Am. Geriatr. Soc., vol. 70, no. 12, pp. 3637–3640, Dec. 2022.
M. Demasi et al., “Optimizing pain management following kidney stone surgery: can we avoid narcotics?,” World J. Urol., vol. 40, no. 12, pp. 3061–3066, Nov. 2022.
C. E. Freiermuth et al., “Genetic Variants Associated With Opioid Use Disorder,” Clin. Pharmacol. Ther., vol. 113, no. 5, pp. 1089–1095, May 2023.
L.-L. Tay, S. Poirier, A. Ghaemi, J. Hulse, and S. Wang, “Iodide Functionalized Paper-Based SERS Sensors for Improved Detection of Narcotics,” Front. Chem., vol. 9, Sep. 2021.
S. Yennurajalingam et al., “Genetic Factors Associated With Pain Severity, Daily Opioid Dose Requirement, and Pain Response Among Advanced Cancer Patients Receiving Supportive Care,” J. Pain Symptom Manage., vol. 62, no. 4, pp. 785–795, Oct. 2021.
S. Mohanty, M. Shin, D. Casper, and C. Saifi, “Postoperative Prescription of Low-dose Narcotics Yields Equivalent Pain Outcomes Compared to High-dose Narcotics in Opioid-naïve Patients Undergoing Spine Surgery,” Spine (Phila. Pa. 1976)., vol. 46, no. 24, pp. 1748–1757, Dec. 2021.
A. Kasim, M. S. Karim, S. Muchtar, A. Asis, M. S, and A. Tenri, “School Drug Education and Leadership Agility: Narcotics Crime Study in Children,” Asian J. Univ. Educ., vol. 17, no. 4, p. 388, Nov. 2021.
E. E. Martinez, P. Melvin, C. Callif, A. D. Turner, S. Hamilton, and N. M. Mehta, “Postpyloric vs gastric enteral nutrition in critically ill children: A single‐center retrospective cohort study,” J. Parenter. Enter. Nutr., vol. 47, no. 4, pp. 494–500, May 2023.
X. Zeng, J. Li, F. Yang, and R. Xia, “The effect of narcotics on ferroptosis-related molecular mechanisms and signalling pathways,” Front. Pharmacol., vol. 13, Oct. 2022.
P. Kuźnicki and K. Neubauer, “Emerging Comorbidities in Inflammatory Bowel Disease: Eating Disorders, Alcohol and Narcotics Misuse,” J. Clin. Med., vol. 10, no. 19, p. 4623, Oct. 2021.
E. Bäckryd, M. Heilig, and M. Hoffmann, “Opioid availability statistics from the International Narcotics Control Board do not reflect the medical use of opioids: comparison with sales data from Scandinavia,” Scand. J. Pain, vol. 21, no. 4, pp. 696–706, Oct. 2021.
A. Truong, L. Yao, P. R. Fleshner, and K. N. Zaghiyan, “Feasibility of opioid‐free surgery for inflammatory bowel disease,” Color. Dis., vol. 25, no. 5, pp. 976–983, May 2023.
K. J. Smith, S. Cimaroli, R. Loo, R. J. Havlik, A. D. Denny, and K. A. Klement, “Pediatric Outcomes following Cranial Vault Remodeling with Restricted Use of Postoperative Narcotics: A Retrospective Review,” Plast. Reconstr. Surg., vol. 150, no. 6, pp. 1293e-1299e, Dec. 2022.
J. N. Bamberger et al., “A prospective randomized study evaluating the necessity of narcotics following ureteroscopy for urinary stone disease,” World J. Urol., vol. 40, no. 10, pp. 2567–2573, Aug. 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Tri Harningsih, Muhammad Saiful Amin , Siwi Diyah Purwita Utami
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
